We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$76.2B
AUM Growth
+$3.6B
Cap. Flow
-$379M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.27%
Holding
781
New
70
Increased
299
Reduced
299
Closed
89

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$114M
2
META icon
Meta Platforms (Facebook)
META
+$87.2M
3
NFLX icon
Netflix
NFLX
+$77.3M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$65.6M
5
ACN icon
Accenture
ACN
+$58.8M

Sector Composition

Rank Sector Weight
1 Technology 27.59%
2 Consumer Discretionary 17.53%
3 Communication Services 17.38%
4 Healthcare 13.08%
5 Financials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIR icon
126
AAR Corp
AIR
$5.76B
$51.7M 0.07%
790,267
+134,215
+20% +$8.88M
KNSL icon
127
Kinsale Capital Group
KNSL
$8.51B
$51.2M 0.07%
110,075
-1,549
-1% -$685K
MOG.A icon
128
Moog Inc Class A
MOG.A
$12.8B
$50.8M 0.07%
251,490
-7,542
-3% -$1.42M
SKX
129
DELISTED
Skechers
SKX
$50.3M 0.07%
752,067
+49,734
+7% +$3.26M
PATK icon
130
Patrick Industries
PATK
$2.85B
$49.4M 0.06%
520,281
-12,008
-2% -$1.01M
BRBR icon
131
BellRing Brands
BRBR
$1.34B
$49M 0.06%
807,759
-394,750
-33% -$21.9M
ACHC icon
132
Acadia Healthcare
ACHC
$2.94B
$48.8M 0.06%
769,568
-11,134
-1% -$804K
SUPN icon
133
Supernus Pharmaceuticals
SUPN
$2.77B
$47.3M 0.06%
1,516,123
-40,038
-3% -$1.25M
CYBR
134
DELISTED
CyberArk
CYBR
$46.7M 0.06%
160,146
-235
-0.1% -$63.6K
OII icon
135
Oceaneering
OII
$4.77B
$45.7M 0.06%
1,838,772
+206,458
+13% +$5.32M
RGA icon
136
Reinsurance Group of America
RGA
$16.1B
$45.7M 0.06%
209,683
+649
+0.3% +$138K
TTEK icon
137
Tetra Tech
TTEK
$9.07B
$45.4M 0.06%
962,192
-1,898
-0.2% -$84.5K
MSCI icon
138
MSCI
MSCI
$40.9B
$45.4M 0.06%
77,801
-41,072
-35% -$22.3M
ROIV icon
139
Roivant Sciences
ROIV
$26.2B
$45.1M 0.06%
3,912,205
+458,601
+13% +$5.22M
THC icon
140
Tenet Healthcare
THC
$21.1B
$44.9M 0.06%
270,300
-44,011
-14% -$6.66M
ASPN icon
141
Aspen Aerogels
ASPN
$518M
$44.8M 0.06%
1,619,320
+300,076
+23% +$7.51M
ABEV icon
142
Ambev
ABEV
$46.4B
$44.7M 0.06%
18,331,822
-559,283
-3% -$1.25M
KAI icon
143
Kadant
KAI
$3.99B
$44.4M 0.06%
131,449
-1,531
-1% -$489K
CRSP icon
144
CRISPR Therapeutics
CRSP
$5.17B
$44.4M 0.06%
945,267
-60,946
-6% -$3.09M
VCEL icon
145
Vericel Corp
VCEL
$2.31B
$43.9M 0.06%
1,040,070
-23,930
-2% -$1.14M
COLM icon
146
Columbia Sportswear
COLM
$2.94B
$43.8M 0.06%
526,526
-32,697
-6% -$2.62M
EVTC icon
147
Evertec
EVTC
$1.78B
$43.5M 0.06%
1,282,462
-29,533
-2% -$984K
IBP icon
148
Installed Building Products
IBP
$6.49B
$43M 0.06%
174,736
-4,033
-2% -$913K
PARA
149
DELISTED
Paramount Global Class B
PARA
$42.1M 0.06%
3,964,216
-46,295
-1% -$503K
NE icon
150
Noble Corp
NE
$6.51B
$41.3M 0.05%
1,141,545
-31,679
-3% -$1.28M

Similar funds

Loomis, Sayles & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Loomis, Sayles & Company held 781 positions worth $76.2B, up 5% from $72.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loomis, Sayles & Company's Q3 2024 filing shows 70 new, 299 increased, 299 reduced and 89 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M. The largest sale was Oracle, an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q3 2024 buy was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M.
  • Loomis, Sayles & Company added most to Nike in Q3 2024, an estimated $510M increase.
  • Loomis, Sayles & Company's biggest Q3 2024 reduction was Oracle, cutting an estimated $114M.
  • Loomis, Sayles & Company fully exited Simply Good Foods in Q3 2024, selling an estimated $58.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 46% of its $76.2B portfolio in Q3 2024.
  • Loomis, Sayles & Company opened 70 new positions and closed 89 in Q3 2024.
  • Loomis, Sayles & Company's portfolio value rose 5% quarter-over-quarter to $76.2B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2024, filed 13 Nov 2024.